J&J decides not to conduct trials in India for its COVID-19 vaccine – ET

Health News
FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

(Corrects to remove extraneous words in first paragraph)

(Reuters) – Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India, the Economic Times reported on Tuesday, citing a company spokesperson.

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn’t have to do that now since India has scrapped that requirement, according to the report. (bit.ly/3h2x358)

The company is exploring how to accelerate the availability of its vaccine in India, the Economic Times said.

J&J did not immediately respond to a Reuters request for comment.

Source: Read Full Article

Related posts:
  1. India opens up immunisation to more people, vaccine exports to dwindle
  2. India's Maharashtra shuts most manufacturing, restricts e-commerce to fight COVID-19
  3. Italy health ministry recommends J&J vaccine for over 60s
  4. Global concern grows as COVID-19 variant ravages rural India
  5. India battles rash of "black fungus" cases hitting COVID-19 patients